Actively Recruiting
Monitoring Multigene Methylation Changes to Evaluate Treatment Response in Esophageal Cancer Patients Undergoing Surgery or Chemoradiotherapy
Led by Xijing Hospital · Updated on 2026-08-27
300
Participants Needed
9
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating the changes in circulating multigene methylation levels before and after treatment in patients with esophageal cancer. The study aims to see how these methylation changes relate to response rates measured by imaging and serum tumor markers. Secondary goals include examining how methylation patterns relate to progression-free survival, comparing methylation indices to traditional biomarkers, and exploring the use of methylation thresholds to guide therapy adjustments. Participants are grouped based on their treatment approach primary surgical treatment, surgery after neoadjuvant therapy, active surveillance after neoadjuvant therapy, or definitive chemoradiotherapy with or without immunotherapy. Each group undergoes multi-gene methylation testing through blood samples taken at specific intervals depending on the treatment stage, ranging from pre-treatment baselines to up to five years post-treatment. This allows for detailed monitoring of methylation changes over time. During the study, participants will also have regular tumor marker tests, imaging exams such as contrast-enhanced CT, PETCT, ultrasound, X-ray, and MRI, as well as endoscopic evaluations according to their group-specific schedules. These assessments occur from before treatment and continue at multiple time points up to five years after treatment. The study thus tracks disease markers, imaging findings, and methylation levels to understand treatment response and disease progression over a long-term period.
CONDITIONS
Brief Title
Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Esophageal Carcinoma
Research Team
Z
Zhongyang Zhang
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here